INSERRA, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 2.882
EU - Europa 1.148
AS - Asia 1.068
SA - Sud America 316
AF - Africa 165
OC - Oceania 6
Totale 5.585
Nazione #
US - Stati Uniti d'America 2.805
SG - Singapore 530
CN - Cina 361
IT - Italia 356
BR - Brasile 288
IE - Irlanda 272
DE - Germania 152
UA - Ucraina 127
CI - Costa d'Avorio 102
RU - Federazione Russa 87
CA - Canada 69
VN - Vietnam 59
IN - India 40
GB - Regno Unito 36
SN - Senegal 36
SE - Svezia 28
FR - Francia 23
AR - Argentina 12
ZA - Sudafrica 12
BD - Bangladesh 11
IQ - Iraq 10
AT - Austria 8
CH - Svizzera 8
FI - Finlandia 7
JP - Giappone 7
NL - Olanda 7
PL - Polonia 7
ID - Indonesia 6
TR - Turchia 6
AU - Australia 5
BE - Belgio 5
CO - Colombia 5
EC - Ecuador 5
ET - Etiopia 5
GR - Grecia 5
HK - Hong Kong 5
PK - Pakistan 5
UZ - Uzbekistan 5
BA - Bosnia-Erzegovina 4
KR - Corea 4
MA - Marocco 4
MX - Messico 4
AL - Albania 3
ES - Italia 3
LB - Libano 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
NP - Nepal 2
TN - Tunisia 2
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SL - Sierra Leone 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.585
Città #
Santa Clara 450
Dallas 433
Chandler 374
Singapore 303
Dublin 272
Houston 159
Jacksonville 146
Chicago 136
Abidjan 102
Boardman 101
Beijing 80
Ashburn 78
Bremen 77
Lawrence 77
Cambridge 76
Andover 75
Nanjing 67
Des Moines 48
Toronto 48
Catania 47
Grafing 43
Civitanova Marche 42
Dakar 36
Wilmington 35
Los Angeles 28
Council Bluffs 26
Nanchang 26
Saint Petersburg 23
São Paulo 21
San Mateo 19
Shenyang 19
Civitavecchia 16
The Dalles 16
Hanoi 15
Hebei 14
Hefei 14
Kochi 14
Columbus 13
Ottawa 13
Vicenza 13
Ho Chi Minh City 12
Jiaxing 12
Moscow 11
Tianjin 11
Ann Arbor 10
Changsha 10
Brasília 9
Dong Ket 9
New York 9
Rome 8
Atlanta 7
Johannesburg 7
Munich 7
Pune 7
Rio de Janeiro 7
San Giuliano Milanese 7
Seattle 7
Tokyo 7
Warsaw 7
Modena 6
Padova 6
Aci Catena 5
Belo Horizonte 5
Brooklyn 5
Brussels 5
Curitiba 5
Guangzhou 5
Hong Kong 5
Jinan 5
Manchester 5
Messina 5
Palermo 5
Phoenix 5
Porto Alegre 5
Baghdad 4
Campinas 4
Chennai 4
Falls Church 4
Frankfurt am Main 4
Guarulhos 4
Helsinki 4
Liberty Lake 4
Ludwigshafen 4
Manzano 4
Milan 4
Montreal 4
Poplar 4
Recife 4
Seoul 4
Shanghai 4
Washington 4
Zhengzhou 4
Addis Ababa 3
Bernareggio 3
Canberra 3
Cape Town 3
Carapicuíba 3
Denver 3
Dhaka 3
Goiânia 3
Totale 3.932
Nome #
ASSOCIATION OF IRRITABLE BOWEL SYNDROME WITH NON-EROSIVE REFLUX DISEASE 265
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 142
La Fenoverina nel trattamento della sindrome del colon irritabile 139
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CELIAC DISEASE IN EASTERN SICILY AREA 132
Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease? 126
Arterial stiffness is increased in patients with inflammatory bowel disease 109
Crohn's disease during pregnancy 105
Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy 102
Colorectal Endoscopic Polipectomy: A Retrospective Study 99
Uso della mesalazina e del beclometasone dipropionato nella pancolite ulcerosa. Descrizione di un caso clinico 97
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 96
685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 96
CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN INFLAMMATORY BOWEL DISEASE 96
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 96
RISK FACTORS OF COLORECTAL POLYPS IN MALE POPULATION OF SOUTH-EASTERN SICILY 95
Alterazioni carotidee in corso di insufficienza renale cronica 94
Gastrointestinal complications after kidney transplantation 94
Caso clinico: Una rettorragia in un giovane ragazzo 93
Overlapping of gastroesophageal reflux disease and irritable Bowel syndrome 90
Irritable Bowel syndrome: subgroups and relationship with gastroesophageal reflux disease 90
Arterial structure and function in inflammatory bowel disease. 87
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 87
A case of osseous metaplasia in the stomach 86
Linfoma non-Hodgkin ad esordio digiunale (stadio II E 2). Follow-up a medio termine di un caso trattato con chirurgia e terapia sistemica 84
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 84
Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis 82
AORTIC-BRACHIAL STIFFNESS MISMATCH STARTS EARLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE 82
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 81
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 78
PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE INCREASED ARTERIAL STIFFNESS 77
Arterial stiffness in patients with inflammatory bowel diseases 74
Pepsinogen A, Pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics 73
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 73
Clinical significance of cytomegalovirus (CMV) infection in inflammatory bowel disease 72
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 72
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2 72
Arterial stiffness is increased in inflammatory bowel disease, dependent upon inflammation and reduced by immunomodulatory drugs 71
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 71
LEWIS ANTIGEN EXPRESSION AND OTHER PATHOGENIC FACTORS IN THE PRESENCE OF ATROPHIC CHRONIC GASTRITIS IN A EUROPEAN POPULATION 70
EVALUATION OF CROHN'S DISEASE ACTIVITY BY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 70
Prevalenza di HHV6 nelle malattie infiammatorie dell’intestino 66
La clebopride nel trattamento della dispepsia funzionale: studio clinico in doppio cieco v/s placebo 66
Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study 63
Crohn's disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index 63
Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing 63
Protection By Copper (Cu++) Against Ethanol-Induced Gastric Mucosal Injury In The Rat 62
Hiatal Hernia And Reflux Esophagitis: An Endoscopic Study 62
Su1339 Ulcerative Colitis (UC) Diagnosed Over Age 65 Years -An IG-IBD Study 61
Subclinical atherosclerosis in patients with inflammatory bowel diseases: A systematic review and meta-analysis 60
PREVALENZA DI HHV6 NELLE MALATTIE INFIAMMATORIE DELL’INTESTINO 59
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine. A single-blind randomized controlled trial 58
Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox 57
COMPARISON OF ESTIMATING GFR FORMULAS IN ELDERLY 57
Inflammation and aortic stiffness: An individual participant data meta-analysis in patients with inflammatory bowel disease 57
P660. Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 56
A REAL LIFE COMPARISON OF THE EFFECTIVENESS OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTRE EXPERIENCE FROM A REGIONAL NETWORK FOR INFLAMMATORY BOWEL DISEASE 56
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease 53
OC.02.4 THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE 53
P577 A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s disease 50
Estimated GFR and renal sinus section area are independent predictors of renal dysfunction in elderly 48
P181 Diagnostic performance of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) in the evaluation of stenosis and endoscopic recurrence in Crohn's disease 48
Inflammatory bowel diseases and pericarditis 48
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 48
P.05.4 ARTERIAL STIFFNESS IS INCREASED IN IBD PATIENTS 47
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study 47
Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study 47
Omeprazole vs. ranitidine in short-term treatment of Helicobacter pylori positive duodenal ulcer patients 46
P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis 46
P.07.1 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) ARE LESS LIKELY TO PERSIST ON ANTI-TNF THERAPY COMPARED WITH YOUNGER PATIENTS. DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD) 46
Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs 45
P539 Does a change in therapeutic approach modify outcome in IBD patients? A comparison between two cohorts 2004–2007 and 2010–2013 45
Early anti-tumor necrosis factor therapy reduces aortic stiffness in inflammatory bowel disease: a multicentre longitudinal study 44
P545 Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 42
OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS 42
P.05.22 INFLAMMATORY BOWEL DISEASES AND PERICARDITIS 41
P412 The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy 40
OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety 39
Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 29
Totale 5.762
Categoria #
all - tutte 21.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 102 13 38 7 80 17 33 20
2021/2022540 64 81 4 15 86 5 81 18 34 1 17 134
2022/20231.043 86 67 25 171 81 172 4 176 225 5 25 6
2023/2024367 23 57 21 12 16 66 19 28 3 7 83 32
2024/20251.641 20 233 98 79 354 217 65 64 144 155 114 98
2025/20261.006 186 78 501 239 2 0 0 0 0 0 0 0
Totale 5.762